Texas A&M Won NIH Grant for Fertility Research
Researchers have secured $1.65 million to study how paternal epigenetic factors affect pregnancy loss.
Updated on Oct. 1, 2026 in Life Sciences
Live Poll
Do you trust that new medical research will effectively lower the risks of pregnancy loss?
Texas A&M University researchers have received a $1.65 million grant from the National Institutes of Health to examine the role of paternal epigenetics in pregnancy loss. The team will study how sperm histones influence embryo development to improve outcomes for both humans and livestock.
Why it matters
Identifying specific biomarkers in sperm could lead to new methods for predicting and treating pregnancy failure. This work aims to address high rates of early pregnancy loss observed in both cattle and humans.
The study utilizes in vitro fertilization, time-lapse imaging, and genomic analysis to observe sperm from bulls with varying fertility levels. Researchers are specifically investigating how paternal epigenetic contributions are delivered and managed within the early embryo.
The players
Lacey Luense
She serves as an assistant professor in epigenetics at Texas A&M University.
Ky Pohler
He is an administrator at the Texas A&M AgriLife Animal Reproductive Biotechnology Center.
National Institutes of Health
This federal agency is the primary public health research entity for the United States.
The details
The research team at the Texas A&M AgriLife Animal Reproductive Biotechnology Center is focusing on sperm histones to understand their impact on conception. By comparing sperm with different epigenetic signatures, they hope to map how these factors contribute to the 50% of pregnancies that end prematurely in cattle and humans.
Timeline
The Animal Reproductive Biotechnology Center opened in 2025.
Researchers anticipate identifying predictive biomarkers within the next five years.
Deeper Dive
This project follows the research mandate established by the Texas A&M AgriLife Animal Reproductive Biotechnology Center. The work represents a significant expansion of the institution's ongoing efforts to map reproductive health metrics through advanced genomic technology.
Future applications of this research may include diagnostic screenings that identify infertility risks based on sperm epigenetics. Such breakthroughs could eventually lower costs and improve success rates for assisted reproductive technologies.
The takeaway
Understanding paternal epigenetic factors shifts the focus of reproductive health research beyond the maternal environment. This study highlights the critical role of sperm health in successful embryo development for both agricultural and medical applications.
Further reading
Learn more about advancements in Life Sciences at Texas A&M.
Source note: This article includes information reported by Thefencepost.
Live Poll
Do you trust that new medical research will effectively lower the risks of pregnancy loss?
